Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: The ALTITUDE REDUCES study

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 9, 2011, Pages 1023-1029

  Gilliam, F Roosevelt ^a   Hayes, David L ^b   Boehmer, John P ^c   Day, John ^d   Heidenreich, Paul A ^e   Seth, Milan ^f   Jones, Paul W ^f   Stein, Kenneth M ^f   Saxon, Leslie A ^g  

^a Mayo Clinic ^*

^b MAYO CLINIC   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d Intermountain Heart Rhythm Specialists   (United States)

^e STANFORD UNIVERSITY   (United States)

^f BOSTON SCIENTIFIC CORPORATION   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

cardiac resynchronization therapy D; detection rates; implantable cardioverter defibrillator; ventricular fibrillation; ventricular tachycardia

Indexed keywords

ADULT; AGED; ANTITACHYCARDIA PACING; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CONVULSIVE THERAPY; DEFIBRILLATOR; DUAL ZONE PROGRAMMING; EVALUATION AND FOLLOW UP; FEMALE; HEART PACING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SHOCK; SINGLE ZONE PROGRAMMING; SURVIVAL; TACHYCARDIA;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FOLLOW-UP STUDIES; HUMANS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 80052832235     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02086.x     Document Type: Article

References (23)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,: Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Sudden Cardiac Death in Heart Failure Trial (SCD-HefT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. (Pubitemid 40110811)
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM,: Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.
4. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH,: Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359: 1009-1017.
5. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrew ML, Hall WJ, Moss AJ,: MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365. (Pubitemid 351443082)
6. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A,: Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006; 113: 776-782.
7. Catanchin A, Anderson L, Jones S, Ward D,. When life-saving devices terminate life. J Cardiovasc Electrophysiol 2008; 19: 316-318. (Pubitemid 351294630)
8. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK,: PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008; 52: 541-550.
9. Saxon LA, Bristow M, Boehmer J, Krueger S, Kass D, De Marco T, Carson P, DiCarlo L, Feldman A, Galle E, Echland F,: Predictors of sudden cardiac death and appropriate shock in the COMPANION Trial. Circulation 2006; 114: 2766-2772.
10. Corbisiero R, Lee MA, Nabert DR, Coman JA, Breiter DJ, Schwartz M, McKittrick E, Zhang Y,: Performance of a new single-chamber ICD algorithm: Discrimination of supraventricular and ventricular tachycardia based on vector timing and correlation. Europace 2006; 8: 1057-1061. (Pubitemid 44896802)
11. Lee MA, Corbisiero R, Nabert DR, Coman JA, Giudici MC, Tomassoni GF, Turk KT, Breiter DJ, Zhang Y,. Clinical results of an advanced SVT detection enhancement algorithm. Pacing Clin Electrophysiol 2005; 28: 1032-1040. (Pubitemid 43951405)
12. Klein GJ, Gillberg JM, Tang A, Inbar S, Sharma A, Unterberg-Buchwald C, Dorian P, Moore H, Duru F, Rooney E, Becker D, Schaaf K, Benditt D,: Worldwide Wave Investigators. Improving SVT discrimination in single-chamber ICDs: A new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol 2006; 17: 1310-1319. (Pubitemid 44808550)
13. Theuns DA, Rivero-Ayerza M, Goedhart DM, Miltenburg M, Jordaens LJ,. Morphology discrimination in implantable cardioverter-defibrillators: Consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 2008; 10: 1060-1066.
14. Wathen MS, Degroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ,: PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591-2596. (Pubitemid 39453007)
15. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM,: EMPIRIC Trial Investigators. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: Results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006; 48: 330-339.
16. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B,: American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235.
17. Saxon LA, Boehmer JP, Neuman S, Mullin CM,. Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): Design and rationale. J Card Fail 2007; 13: 241-246. (Pubitemid 46766636)
18. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP,: Long-term outcome after ICD and CRT implant and the influence of remote device follow-up: The ALTITUDE survival study. Circulation 2010; 122: 2359-2367.
19. Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S,: Death without prior appropriate implantable cardioverter-defibrillator therapy: A competing risk study. Circulation 2008; 117: 1918-1926. (Pubitemid 351543467)
20. Gray RJ,: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist 1988; 16: 1140-1154.
21. Gunderson BD, Abeyratne AI, Olson WH, Swerdlow CD,: Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks. Pacing Clin Electrophysiol 2007; 30: 157-165. (Pubitemid 46333670)
22. Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG,: Review of registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010; 7: 1340-1345.
23. Saxon LA,. Verbal Communication with Tachycardia Support Teams from Medtronic, Inc., St. Jude Medical and Boston Scientific Corporation, 6 October 2010.